| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2862728 | American Journal of Hypertension | 2007 | 8 Pages |
Abstract
Our results suggest that in mildly hypertensive patients without organ damage zofenopril, beyond its BP-lowering effects and through its sustained antioxidant activity, offers important advantages in reducing endothelial activation.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Anna Fratta Pasini, Ulisse Garbin, Maria Cristina Nava, Chiara Stranieri, Michele Pellegrini, Veronica Boccioletti, Maria Laura Luchetta, Paolo Fabrizzi, Vincenzo Lo Cascio, Luciano Cominacini,